Improving HIV disclosure to sexual partners via assisted partner notification services: A mixed-method study on utilization, barriers, and facilitators
November 20, 2025 | MedPage Today
Background: The global burden of HIV remains substantial, with Tanzania among the most aff...


Fastställande av avstämningsdag för sammanläggning av aktier i Biosergen
November 20, 2025 | Placera
Fastställande av avstämningsdag för sammanläggning av aktier i Biosergen STOCKHOLM, den 2...


Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study.
November 19, 2025 | MedPage Today
BACKGROUND AND AIMS: Conflicting data on hepatocellular carcinoma (HCC) survival in people...


Scripps Research scientists receive $1.1 million to advance AI modeling for HIV vaccine ...
November 19, 2025 | Stigmabase | HIV
...


Lever du med HIV?
November 19, 2025 | Gefle Dagblad
Varje år får omkring 450 personer i Sverige en HIV-diagnos. Forskningen har gjort enorma f...


Merck Says Its Two-Drug Regimen For HIV Treatment Proven Non-Inferior To Gilead’s Biktarvy In Study
November 19, 2025 | Asianetnews
Merck (MRK) on Thursday said that its investigational once-daily, oral, two-drug, single-t...


Scripps Research scientists receive $1.1 million to advance AI modeling for HIV vaccine development
November 19, 2025 | FirstWord Pharma
LA JOLLA, CA—As of 2024, over 40 million people in the world are diagnosed with human immu...


Merck’s oral HIV treatment meets main goal in late-stage study
November 19, 2025 | KQDS-FM
Reuters) -Merck said on Wednesday that its experimental oral HIV treatment met the main go...


Merck HIV Drug vs. Biktarvy: Study Results | TradingView
November 19, 2025 | Time.news
... 18 Merck’s New HIV Treatment Shows Promise, Matching Gilead’s biktarvy in Trial Table...


Till minne av Anna Karlsson (1958-2025)
November 19, 2025 | Nyheter från Karolinska Institutet
Professor Anna Karlsson, framträdande virus- och cancerforskare samt medlem av Nobelförsam...